Kuros Biosciences AG (SWX:KURN)

Kuros Biosciences AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.73	19.77	19.76	16.87	26.03	31.4
Cash & Short-Term Investments	9.73	19.77	19.76	16.87	26.03	31.4
Cash Growth	-47.22%	0.03%	17.12%	-35.17%	-17.11%	-2.14%
Accounts Receivable	27.51	30.21	14.69	7.61	3.05	1.85
Other Receivables	16.94	9.98	3.01	1.43	0.87	0.39
Receivables	44.45	40.2	17.7	9.05	3.91	2.25
Inventory	26.36	21.35	10.36	5.77	3.43	1.93
Prepaid Expenses	2.65	1.35	1.26	0.61	0.58	0.51
Total Current Assets	83.19	82.67	49.08	32.29	33.95	36.08
Property, Plant & Equipment	19.41	4.68	3.32	3.14	2.51	2.68
Goodwill	23.72	24.3	21.31	29.06	31.7	36.63
Other Intangible Assets	15.18	16.59	16.44	19.6	20.99	24.8
Long-Term Deferred Tax Assets	6.68	5.32	2.56	0.76	0.55	-
Other Long-Term Assets	0.77	0.32	-	0.02	-	-
Total Assets	148.94	133.88	92.7	84.87	89.7	100.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14.44	13.81	7.58	1.55	1.41	0.93
Accrued Expenses	27.98	27.18	14.76	9.42	5.44	3.94
Current Portion of Leases	2.04	0.65	0.58	0.69	0.45	0.42
Other Current Liabilities	-	0.5	-	-	6.32	7.09
Total Current Liabilities	44.45	42.14	22.92	11.65	13.61	12.38
Long-Term Leases	8.03	0.74	1.39	1.86	1.62	2.01
Pension & Post-Retirement Benefits	-	-	0.15	-	-	0.39
Long-Term Deferred Tax Liabilities	3.63	2.94	0.36	-	-	0.98
Other Long-Term Liabilities	3.58	3.58	3.46	4.01	-	-
Total Liabilities	59.69	49.39	28.28	17.52	15.23	15.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	3.27	3.23	3.07	4.37	3.95	3.6
Additional Paid-In Capital	67.2	66.87	64.84	87.07	173.2	169.58
Retained Earnings	-33	-37.79	-40.76	-50.06	-125.27	-111.44
Treasury Stock	-	-	-	-0.02	-0.02	-0.02
Comprehensive Income & Other	51.79	52.17	37.27	25.99	22.6	22.72
Shareholders' Equity	89.26	84.48	64.42	67.35	74.47	84.44
Total Liabilities & Equity	148.94	133.88	92.7	84.87	89.7	100.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10.07	1.39	1.97	2.54	2.07	2.43
Net Cash (Debt)	-0.33	18.38	17.8	14.33	23.96	28.97
Net Cash Growth	-	3.28%	24.20%	-40.19%	-17.31%	-1.34%
Net Cash Per Share	-0.01	0.44	0.48	0.39	0.71	0.88
Filing Date Shares Outstanding	40.05	39.15	37.87	36.77	36.54	32.79
Total Common Shares Outstanding	40.05	39.15	37.87	36.77	36.54	32.79
Working Capital	38.74	40.52	26.16	20.64	20.34	23.7
Book Value Per Share	2.23	2.16	1.70	1.83	2.04	2.57
Tangible Book Value	50.36	43.59	26.67	18.69	21.77	23.01
Tangible Book Value Per Share	1.26	1.11	0.70	0.51	0.60	0.70
Machinery	6.12	5.18	2.94	2.08	1.64	1.3
Construction In Progress	3.97	0.62	-	-	-	-
Leasehold Improvements	2.38	0.1	0.07	0.05	0.05	0.04

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error